COMP <GO>
THC vs MRK // RSI-14 & 200D SMA MOMENTUM
Tenet Healthcare Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: THC 7
— MRK 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: THC
LAST: $273.25 (+0.99%) • MKT CAP: $21.79B
rsi-technicals
58.2
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
rsi-technicals
56.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.60% | 20.70% | +6.90 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.3x | 15.3x | -9.00 | THC | /valuation <GO> |
| Free Cash Flow Yield | 11.61% | 3.42% | +8.19 | THC | /fcf-yield <GO> |
| Operating Margin | 16.50% | 34.30% | -17.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 11.10% | 28.10% | -17.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | 1.30% | +1.80 | THC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.08 | 5.19 | -3.11 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 58.2 | 56.9 | +1.30 | THC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.92 | +0.05 | THC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 18.4x | -9.80 | THC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.79B | $361.02B | -$339.24B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THC REV | MRK REV | THC GROSS % | MRK GROSS % | THC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.31B | $65.01B | 44.0% | 74.8% | $2.53B | $12.36B |
| FY 2024 | $20.68B | $64.17B | 44.0% | 76.3% | $1.12B | $18.10B |
| FY 2023 | $20.56B | $60.12B | 44.0% | 44.0% | $1.45B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THC // BETA 0.97
MRK // BETA 0.92